Hillsdale Investment Management Inc. Viatris Inc Transaction History

Hillsdale Investment Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $58,630 - $66,885	6,500 Added 16.19%	46,650 $465,000
Q1 2023 May 10, 2023	SELL	$9.2 - $12.26 $86,940 - $115,857	-9,450 Reduced 19.05%	40,150 $386,000
Q4 2022 Feb 13, 2023	SELL	$8.72 - $11.56 $37,496 - $49,708	-4,300 Reduced 7.98%	49,600 $552,000
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $536,305 - $661,353	53,900 New	53,900 $565,000
Q1 2021 Apr 22, 2021	SELL	$13.59 - $18.54 $1,494 - $2,039	-110 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $1,573 - $2,061	110 New	110 $2,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.